t
AdvancedAdvT Limited announced that on 23 May 2024, Barbara Firth, a Non-Executive Director and Senior Independent Director, purchased 70,000 ordinary shares. These shares were acquired at a price of £1.41 per share, bringing her total beneficial interest in the Company to 70,000 Ordinary Shares, which represents 0.05% of the total issued share capital.
| Date | 24 May 2024 |
| Time | 11:15:00 |
| Category | Director/PDMR dealings |
| ID | 8563P |
24 May 2024
AdvancedAdvT Limited
PDMR Dealings
AdvancedAdvT Limited (AIM: ADVT, "AdvT", "the Group"), the international software solutions provider for the business solutions, healthcare compliance, and human capital management sectors has been notified that on 23 May 2024 Barbara Firth, Non-Executive Director and Senior Independent Director, purchased 70,000 ordinary shares of no par value ("Ordinary Shares") at a price of £1.41 per Ordinary Share.
Following the completion of the transaction, Barbara Firth's total beneficial interest in the Company stands at 70,000 Ordinary Shares, representing 0.05% of the total issued share capital.
Details of the transaction can be found in the Notification of Dealing Form below.
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
Barbara Firth |
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Non-Executive Director and Senior Independent Director |
|||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
AdvancedAdvT Limited |
|||
|
b)
|
LEI
|
254900WYO35S1T334A28 |
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Ordinary Shares of no par value fully paid (DI) |
|||
|
|
|
||||
|
Identification code |
VGG0103J1075 |
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
Purchase of Ordinary Shares |
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
£1.41 |
70,000 |
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
|
||||
|
- Aggregated volume |
n/a |
||||
|
|
|
||||
|
- Price |
n/a |
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
23 May 2024 |
|||
|
f)
|
Place of the transaction
|
London Stock Exchange, AIM Market (XLON) |
|||
Enquiries:
|
AdvancedAdvT Limited |
|
|
Vin Murria, Chairperson Gavin Hugill, Chief Financial Officer |
c/o Meare Consulting |
|
|
|
|
Singer Capital Markets (Nominated Adviser and Broker) |
Tel: 020 7496 3000 |
|
Philip Davies / Asha Chotai / Sam Butcher |
|
|
|
|
|
KK Advisory (Investor Relations) |
Tel: 020 7039 1901 |
|
Kam Bansil |
|
|
Meare Consulting |
|
|
Adrian Duffield |
Tel: 07990 858548 |
Note to Editors
AdvancedAdvT Limited (AdvT) provides software solutions and platforms across two business transformational areas: business solutions & healthcare compliance, and human capital management.
The Group's operations are IBSS (financial management software), CHKS (AI based healthcare intelligence compliance and accreditation software), Retain (global resource planning and talent management software) and WFM (workforce management software provider).
AdvT is an agent for change. The Group enables the delivery of Artificial Intelligence ("AI"), data analytics and business intelligence, all of which are key future drivers for growth in these sectors where long term digitisation trends are set to transform the workplace for professionals.
AdvT is developing both organically and through acquisitions, by expanding its presence across adjacent markets, geographical boundaries and digital sectors.